Investing.com -- Advanced Micro Devices received upgrades from both Goldman Sachs and Bernstein after the chipmaker reported stronger-than-expected first-quarter results and provided a robust second-quarter outlook, with analysts pointing to agentic AI as a key driver of the company’s accelerating growth.
Investing.com -- Advanced Micro Devices received upgrades from both Goldman Sachs and Bernstein after the chipmaker reported stronger-than-expected first-quarter results and provided a robust second-quarter outlook, with analysts pointing to agentic AI as a key driver of the company’s accelerating growth.
Elanco press release ( ELAN ): Q1 Non-GAAP EPS of $0.40 beats by $0.06 . Revenue of $1.37B (+15.1% Y/Y) beats by $90M . FY26 revenue consensus of $5.00B, EPS consensus of $1.03 Full Year 2026 Guidance: Raising innovation revenue target to $1.2 billion Raising revenue guidance to $5,010 million to $5,085 million, or 5% to 7% organic constant currency growth Raising Adjusted EBITDA to $975 million t...
Elanco press release ( ELAN ): Q1 Non-GAAP EPS of $0.40 beats by $0.06 . Revenue of $1.37B (+15.1% Y/Y) beats by $90M . FY26 revenue consensus of $5.00B, EPS consensus of $1.03 Full Year 2026 Guidance: Raising innovation revenue target to $1.2 billion Raising revenue guidance to $5,010 million to $5,085 million, or 5% to 7% organic constant currency growth Raising Adjusted EBITDA to $975 million to $1,005 million, a year-over-year increase of 10% at midpoint Raising Adjusted EPS of $1.03 to $1.09, a year-over-year increase of 13% at midpoint Improving year-end net leverage ratio target to 3.0x to 3.2x Adjusted EBITDA Shares -1% PM. More on Elanco Elanco Animal Health: Relying On Innovation To Drive Growth Elanco Animal Health Incorporated (ELAN) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript Elanco Animal Health Incorporated (ELAN) Presents at Leerink Global Healthcare Conference 2026 Transcript Elanco Q1 2026 Earnings Preview Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics MASI among Q4 moves